Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Sponsorship of International Medicinal Cannabis …

SAN DIEGO, May 16, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is a main sponsor for the “A Look Into the Future” International Medicinal Seminar in Rio de Janeiro, Brazil, on May 18-19.

HempMeds® Brasil was the first company authorized by ANVISA to import a cannabidiol (CBD)-based product into Brazil for those suffering from various specific medical conditions.

“Our international presence is important to the future of the company because we want to show that we care about access to CBD around the world, not just in the U.S.,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

The “A Look Into the Future” International Medicinal Seminar was organized to discuss access to cannabis in the country and its insertion into public health. During the two-day event, doctors from across the globe will share their efforts to pioneer cannabis research. There will also be several patient panels where medical cannabis users will share testimonials on how cannabis has influenced their health.

During the event, a manifesto will be signed and presented by public and private companies, associations and self-cultivation experts to urge Brazilian authorities to regulate the cultivation and domestic production of cannabis for therapeutic purposes.

“Our Company is proud to sponsor such a prestigious seminar,” said HempMeds® Brasil Vice President Caroline Heinz. “We hope that the manifesto being presented at the event will present itself as a call-to-action for the country’s authorities to help us create a safe and legal cannabis market.”

For more information about the company’s participation in the symposium, please follow @HempMedsBrasil on Facebook.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry

Bookmark the permalink.